VAR has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
This is the expense the company spent on research and development. Varian Medical Systems Inc's research and development for the three months ended in Mar. 2014 was $61 Mil. Its research and development for the trailing twelve months (TTM) ended in Mar. 2014 was $229 Mil.
This is the expense the company spent on research and development.
Varian Medical Systems Inc Research & Development for the trailing twelve months (TTM) ended in Mar. 2014 was 53.335 (Jun. 2013 ) + 56.853 (Sep. 2013 ) + 58.003 (Dec. 2013 ) + 60.677 (Mar. 2014 ) = $229 Mil.
If competitive advantage is created by a patent or tech advantage, at some point it will disappear.
High R&D usually dictates high SG&A which threatens the competitive advantage.
Varian Medical Systems Inc Annual Data
|Research & Development||72||82||100||117||136||147||157||171||186||208|
Varian Medical Systems Inc Quarterly Data
|Research & Development||44||47||49||46||47||51||53||57||58||61|